Infectious dose of Senecavirus A in market weight and neonatal pigs

• Published in: PloS one 2022-04, Vol.17 (4), p.e0267145
• Main Authors: Buckley, Alexandra, Lager, Kelly
• Format: Article
• Language: English
• Subjects: Agriculture; Animal diseases; Animals; Antibodies; Antibodies, Neutralizing; Antibody response; Biology and Life Sciences; Biosecurity; Dilution; Disease control; Diseases; Disinfection; Distribution; Environmental aspects; Foot & mouth disease; Foot and mouth disease; Foot-and-Mouth Disease Virus; Health aspects; Hogs; Housing; Infant mortality; Laboratories; Meat; Medicine and Health Sciences; Neonates; Newborn babies; Pathogenesis; People and places; Picornaviridae; Picornaviruses; Swine; Swine Diseases; Viruses; Weaning
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0267145

Foot-and-mouth disease virus (FMDV) is a picornavirus that produces a highly transmissible vesicular disease that can devastate meat and dairy production to such an extent that FMDV-free countries commit significant economic resources to maintain their FMDV-free status. Senecavirus A (SVA), also a picornavirus, causes vesicular disease in swine that is indistinguishable from FMDV. Since 2015, SVA outbreaks have been reported around the world requiring FMDV-free countries to investigate these cases to rule out FMDV. Understanding the pathogenesis of the SVA and its ability to transmit to naïve populations is critical to formulating control and prevention measures, which could reduce FMDV investigations. The primary objective of this study was to determine the infectious dose of SVA in market weight and neonatal pigs. A 2011 SVA isolate was serially hundred-fold diluted to create four challenge inoculums ranging from 106.5 to 100.5 TCID50/ml. Four market weight pigs individually housed were intranasally inoculated with 5 mL of each dose (n = 16). Serial ten-fold dilutions were used to create 6 challenge inoculums ranging from 105.5 to 100.5 TCID50/ml for neonatal pigs. Again, four animals in individual housing were challenged orally with 2 mL of each dose (n = 24). Detection of SVA by PCR in collected samples and/or neutralizing antibody response was utilized to classify an animal as infected. The minimum infectious dose for this study in market weight animals was 1,260 TCID50/ml (103.1 TCID50/ml) and for neonates it was 316 TCID50/ml (102.5 TCID50/ml). Knowledge of the infectious dose of SVA can guide biosecurity and disinfection measures to control the spread of SVA.